Lithium in patients with chronic kidney disease - To continue versus discontinue?

Bipolar Disord. 2022 Aug;24(5):549-550. doi: 10.1111/bdi.13209. Epub 2022 Mar 30.

Authors

Mehak Pahwa^{1

2}, Balwinder Singh¹

Affiliations

¹ Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
² Department of Psychiatry and Behavioral Sciences, University of Louisville, Louisville, Kentucky, USA.

PMID: 35332966
DOI: 10.1111/bdi.13209

No abstract available

Publication types

Comment

MeSH terms

Antimanic Agents / therapeutic use
Bipolar Disorder* / drug therapy
Humans
Lithium / therapeutic use
Renal Insufficiency, Chronic* / drug therapy

Substances

Antimanic Agents
Lithium